Applied DNA Sciences Signs New Licensing Agreement with Himatsingka America
June 27 2017 - 09:48AM
Business Wire
New Agreement to Empower Large-Scale Supply
Chain Security within the Cotton Industry
Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,”
NASDAQ: APDN), is pleased to announce the signing of a new
licensing agreement with Himatsingka America, Inc. (“Himatsingka”,
“HAI”), which is a part of the Himatsingka Group.
“This new agreement represents a strengthened partnership
between Applied DNA and Himatsingka, as both companies are
committed to meeting the need for supply chain traceability,
transparency and trust within the cotton industry. Applied DNA is
looking forward to continuing to work with the Himatsingka Group,
and we are excited at the opportunity to expand market awareness
and implement the technology into additional cotton supply chains.”
stated Dr. James A. Hayward, President and CEO of Applied DNA.
Commenting on the development, Shrikant Himatsingka, the
Managing Director & CEO - Himatsingka Group, said: “We look
forward to taking the Applied DNA technology platform global and
continuing to bring cutting edge track and trace capabilities to
benefit stakeholders across the cotton value chain. The Himatsingka
Group will leverage its world-class manufacturing and distribution
capabilities to ensure that these innovations by Applied DNA find
their place across global shelves and penetrate new categories of
products.”
About Himatsingka America
Himatsingka America is a part of The Himatsingka Group. The
Himatsingka Group is a vertically integrated home textile major
with a global footprint. On the manufacturing front, the group
operates one of the largest capacities in the world for producing
bed linen, ultrafine count cotton yarn, drapery and upholstery
products. Spread across Asia, Europe and North America, its retail
and wholesale distribution divisions carry some of the most
prestigious brands in the home textile space and caters to private
label programs of major retailers across these geographies.
About Applied DNA
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT™” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products. SigNature® DNA describes
the core technology ingredient that is at the heart of a family of
uncopyable, security and authentication solutions such as
SigNature® T and fiberTyping®, targeted toward textiles and
apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention,
and digitalDNA®, providing powerful track-and-trace. All provide a
forensic chain of evidence, and can be used to prosecute
perpetrators. Applied DNA Sciences is also engaged in the
large-scale production of specific DNA sequences using the
polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017, and May 11, 2017 which are available at
www.sec.gov. APDN undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170627005934/en/
Investor:LHAISanjay Hurry,
212-838-3777sanjay.hurry@lhai.comorMedia:CGPRAngie Mathews,
714-768-1140angie@cgprpublicrelations.comorProgram:MeiLin
Wan,
631-240-8849meilin.wan@adnas.comweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2023 to Mar 2024